Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial | Actual demonstrations on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial
Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial
Evaluation of the effect of Tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

Tofacitinib is used for the treatment of rheumatoid arthritis. Changes in serum creatinine levels with the administration of tofacitinib have created a need to fully understand the impact of tofacitinib on renal function. That is why; authors in this study have evaluated its effect on glomerular filtration rate. 

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: